(Q45723463)

15 December 2017

title

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans (English)

1 reference

15 December 2017

vaccinia virus

1 reference

27

1 reference

15 December 2017

Kent E Kester

14

0 references

Samuel J McConkey

object named as

Samuel J McConkey

1

0 references

Adrian V. S. Hill

28

object named as

Adrian V S Hill

1 reference

15 December 2017

Susanna Dunachie

5

0 references

D. Gray Heppner

17

object named as

D Gray Heppner

1 reference

15 December 2017

3

Vasee S Moorthy

1 reference

15 December 2017

19

Katie Flanagan

1 reference

15 December 2017

7

Jenni M Vuola

1 reference

15 December 2017

6

Geoff Butcher

1 reference

15 December 2017

18

Ansar Pathan

1 reference

15 December 2017

10

Kate Watkins

1 reference

15 December 2017

11

Carolyn M Hannan

1 reference

15 December 2017

26

Robert E Sinden

1 reference

15 December 2017

William H H Reece

2

1 reference

15 December 2017

Daniel Webster

4

1 reference

15 December 2017

Tom J Blanchard

8

1 reference

15 December 2017

Philip Gothard

9

1 reference

15 December 2017

Simone Everaere

12

1 reference

15 December 2017

Karen Brown

13

1 reference

15 December 2017

James Cummings

15

1 reference

15 December 2017

Jackie Williams

16

1 reference

15 December 2017

Nirmalan Arulanantham

20

1 reference

15 December 2017

Mark T M Roberts

21

1 reference

15 December 2017

Michael Roy

22

1 reference

15 December 2017

Geoffrey L Smith

23

1 reference

15 December 2017

Joerg Schneider

24

1 reference

15 December 2017

Tim Peto

25

1 reference

15 December 2017

language of work or name

English

0 references

publication date

25 May 2003

1 reference

15 December 2017

1 reference

15 December 2017

volume

9

1 reference

15 December 2017

issue

6

1 reference

15 December 2017

page(s)

729-735

1 reference

CD8+ T Cell Effector Mechanisms in Resistance to Infection

15 December 2017

cites work

1 reference

Effector and memory T-cell differentiation: implications for vaccine development

21 January 2018

1 reference

T cell-dependent B cell activation

21 January 2018

1 reference

The complexity of protective immunity against liver-stage malaria

21 January 2018

1 reference

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

21 January 2018

1 reference

Adoptive transfer of simian immunodeficiency virus (SIV) naïve autologous CD4(+) cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status

21 January 2018

1 reference

Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.

21 January 2018

1 reference

Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin

21 January 2018

1 reference

Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides

21 January 2018

1 reference

HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen

21 January 2018

1 reference

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

21 January 2018

1 reference

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

21 January 2018

1 reference

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

21 January 2018

1 reference

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

21 January 2018

1 reference

Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.

21 January 2018

1 reference

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

21 January 2018

1 reference

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

21 January 2018

1 reference

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

21 January 2018

1 reference

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies

21 January 2018

1 reference

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

21 January 2018

1 reference

A protein particle vaccine containing multiple malaria epitopes

21 January 2018

1 reference

Development of a preventive vaccine for Ebola virus infection in primates

21 January 2018

1 reference

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

21 January 2018

1 reference

Malaria. A renewed assault on an old and deadly foe.

21 January 2018

1 reference

Common west African HLA antigens are associated with protection from severe malaria

21 January 2018

1 reference

Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes

21 January 2018

1 reference

A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite

21 January 2018

1 reference

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers

21 January 2018

1 reference

The production of mature gametocytes of Plasmodium falciparum in continuous cultures of different isolates infective to mosquitoes

21 January 2018

1 reference

Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection

21 January 2018

1 reference

Estimate of anti-Plasmodium falciparum sporozoite activity in humans vaccinated with synthetic circumsporozoite protein (NANP)3.

21 January 2018

1 reference

A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees

21 January 2018

1 reference

Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR.

21 January 2018

1 reference

Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine

21 January 2018

1 reference

Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques.

21 January 2018

1 reference

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

21 January 2018

1 reference

Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Malaria transmitted to humans by mosquitoes infected from cultured plasmodium falciparum

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Natural polymorphism in the thrombospondin-related adhesive protein of Plasmodium falciparum

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM881

1 reference

Dimensions Publication ID

15 December 2017

1007601222

0 references

1 reference